The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

BACKGROUND/OBJECTIVE: Investigate real-world patients receiving faricimab for the treatment of neovascular age-related macular degeneration (nAMD). SUBJECTS/METHODS: Multicenter, retrospective chart review was conducted on patients treated with faricimab for nAMD from February 2022 to September 2022...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanani, Arshad M., Aziz, Aamir A., Khan, Hannah, Gupta, Ashwin, Mojumder, Ohidul, Saulebayeva, Aigerim, Abbey, Ashkan M., Almeida, David R. P., Avery, Robert L., Banda, Himanshu K., Barakat, Mark R., Bhandari, Ramanath, Chang, Emmanuel Y., Haug, Sara J., London, Nikolas J. S., Mein, Luke, Sheth, Veeral S., Wolfe, Jeremy D., Singer, Michael A., Danzig, Carl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686385/
https://www.ncbi.nlm.nih.gov/pubmed/37173428
http://dx.doi.org/10.1038/s41433-023-02553-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686385/
https://www.ncbi.nlm.nih.gov/pubmed/37173428
http://dx.doi.org/10.1038/s41433-023-02553-5

Ejemplares similares